| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |